These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11673526)

  • 1. Efficient chromosomal mapping of a methylcholanthrene-induced tumor antigen by CTL immunoselection.
    Akilesh S; Dudley ME; Eden PA; Roopenian DC
    J Immunol; 2001 Nov; 167(9):5143-9. PubMed ID: 11673526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens.
    Dudley ME; Roopenian DC
    J Exp Med; 1996 Aug; 184(2):441-7. PubMed ID: 8760797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cloned class I MHC-restricted, CD8+ anti-Meth A cytotoxic T-lymphocytes: recognition of an epitope derived from the Meth A gp110 tumor rejection antigen.
    Fassanito MA; Loftus D; De Leo RM; Law LW; Appella E; De Leo AB
    Cancer Res; 1994 Aug; 54(16):4424-9. PubMed ID: 7519121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome assignment of the tumor-specific antigen of a 3-methylcholanthrene-induced mouse sarcoma.
    Pravtcheva DD; DeLeo AB; Ruddle FH; Old LJ
    J Exp Med; 1981 Sep; 154(3):964-77. PubMed ID: 7276830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene mapping in a murine cell line by immunoselection with cytotoxic T lymphocytes.
    Zuberi AR; Dudley ME; Christianson GJ; Roopenian DC
    Genomics; 1994 Jan; 19(2):273-9. PubMed ID: 7514566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA vaccination primes MHC class I-restricted, simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumors.
    Schirmbeck R; Böhm W; Reimann J
    J Immunol; 1996 Oct; 157(8):3550-8. PubMed ID: 8871655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical components of a DNA fusion vaccine able to induce protective cytotoxic T cells against a single epitope of a tumor antigen.
    Rice J; Buchan S; Stevenson FK
    J Immunol; 2002 Oct; 169(7):3908-13. PubMed ID: 12244189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones.
    Maryanski JL; Boon T
    Eur J Immunol; 1982 May; 12(5):406-12. PubMed ID: 6178608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion mapping by immunoselection against the H-Y histocompatibility antigen further resolves the Sxra region of the mouse Y chromosome and reveals complexity of the Hya locus.
    King TR; Christianson GJ; Mitchell MJ; Bishop CE; Scott D; Ehrmann I; Simpson E; Eicher EM; Roopenian DC
    Genomics; 1994 Nov; 24(1):159-68. PubMed ID: 7896271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro selection of SV40 T antigen epitope loss variants by site-specific cytotoxic T lymphocyte clones.
    Tanaka Y; Tevethia SS
    J Immunol; 1988 Jun; 140(12):4348-54. PubMed ID: 2453578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic T lymphocytes (CTL) against a transforming gene product select for transformed cells with point mutations within sequences encoding CTL recognition epitopes.
    Lill NL; Tevethia MJ; Hendrickson WG; Tevethia SS
    J Exp Med; 1992 Aug; 176(2):449-57. PubMed ID: 1380062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyte.
    Frassanito MA; Mayordomo JI; DeLeo RM; Storkus WJ; Lotze MT; DeLeo AB
    Cancer Res; 1995 Jan; 55(1):124-8. PubMed ID: 7528638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor progression despite efficient tumor antigen cross-presentation and effective "arming" of tumor antigen-specific CTL.
    Nelson DJ; Mukherjee S; Bundell C; Fisher S; van Hagen D; Robinson B
    J Immunol; 2001 May; 166(9):5557-66. PubMed ID: 11313395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha.
    Tüting T; Wilson CC; Martin DM; Kasamon YL; Rowles J; Ma DI; Slingluff CL; Wagner SN; van der Bruggen P; Baar J; Lotze MT; Storkus WJ
    J Immunol; 1998 Feb; 160(3):1139-47. PubMed ID: 9570527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele.
    Crowley NJ; Darrow TL; Quinn-Allen MA; Seigler HF
    J Immunol; 1991 Mar; 146(5):1692-9. PubMed ID: 1671580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of foreign cytotoxic T lymphocyte epitopes to tumor tissues for effective antitumor immunotherapy against pre-established solid tumors in mice.
    Kavunja HW; Lang S; Sungsuwan S; Yin Z; Huang X
    Cancer Immunol Immunother; 2017 Apr; 66(4):451-460. PubMed ID: 28011995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity and mitotic linkage maps in the mouse.
    Henson V; Palmer L; Banks S; Nadeau JH; Carlson GA
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6486-90. PubMed ID: 1677769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruitment of CTL activity by tumor-specific antibody-mediated targeting of single-chain class I MHC-peptide complexes.
    Lev A; Novak H; Segal D; Reiter Y
    J Immunol; 2002 Sep; 169(6):2988-96. PubMed ID: 12218113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of point mutations in the native simian virus 40 tumor antigen, and in synthetic peptides corresponding to the H-2Db-restricted epitopes, on antigen presentation and recognition by cytotoxic T lymphocyte clones.
    Deckhut AM; Tevethia SS
    J Immunol; 1992 May; 148(10):3012-20. PubMed ID: 1374447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.